RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+50.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.65B
AUM Growth
+$3.65B
(+51%)
Cap. Flow
+$447M
Cap. Flow
% of AUM
12.25%
Top 10 Holdings %
Top 10 Hldgs %
23.51%
Holding
147
New
14
Increased
83
Reduced
11
Closed
4
Top Buys
| 1 |
Novavax
NVAX
|
$47.6M |
| 2 |
Centene
CNC
|
$35.9M |
| 3 |
UnitedHealth
UNH
|
$31M |
| 4 |
Edwards Lifesciences
EW
|
$26.8M |
| 5 |
Royalty Pharma
RPRX
|
$24.3M |
Top Sells
| 1 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$42.7M |
| 2 |
Intuitive Surgical
ISRG
|
$18.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$7.9M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$7.48M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$5.41M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Consumer Staples | 1.09% |
| 3 | Consumer Discretionary | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adaptive Biotechnologies
ADPT
$2.01B
| $27.8M | 0.76% | 575,000 +30,000 | +6% | +$1.45M |
|
52
Incyte
INCY
$16.5B
| $26M | 0.71% | 250,000 | – | – |
|
53
Mirum Pharmaceuticals
MIRM
$3.71B
| $25.7M | 0.7% | 1,319,910 +76,910 | +6% | +$1.5M |
|
|
54
Royalty Pharma
RPRX
$15.6B
| $24.3M | 0.67% | +500,000 | New | +$24.3M |
|
55
Inspire Medical Systems
INSP
$2.77B
| $23.1M | 0.63% | 265,000 +65,000 | +33% | +$5.66M |
|
|
KRTX
56
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $22.7M | 0.62% | 203,312 +23,312 | +13% | +$2.6M |
|
57
Acadia Healthcare
ACHC
$2.12B
| $22.6M | 0.62% | 900,000 | – | – |
|
58
Travere Therapeutics
TVTX
$1.56B
| $20.9M | 0.57% | 1,024,261 +449,261 | +78% | +$9.17M |
|
|
ALXN
59
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $20.6M | 0.56% | +183,500 | New | +$20.6M |
|
60
Collegium Pharmaceutical
COLL
$1.22B
| $20.6M | 0.56% | 1,175,000 | – | – |
|
61
Aprea Therapeutics
APRE
$9.09M
| $20.1M | 0.55% | 518,290 +18,290 | +4% | +$709K |
|
|
ADAP
62
Adaptimmune Therapeutics
ADAP
$15.6M
| $19.9M | 0.55% | 1,986,910 +786,910 | +66% | +$7.88M |
|
63
Allogene Therapeutics
ALLO
$251M
| $18.9M | 0.52% | 440,468 +190,468 | +76% | +$8.16M |
|
64
HealthEquity
HQY
$7.72B
| $18.8M | 0.52% | 320,100 +15,100 | +5% | +$886K |
|
|
ODT
65
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $18.5M | 0.51% | 437,231 +7,231 | +2% | +$306K |
|
66
Phreesia
PHR
$1.88B
| $18.4M | 0.51% | 651,500 +86,500 | +15% | +$2.45M |
|
67
uniQure
QURE
$896M
| $18.3M | 0.5% | 407,133 +7,133 | +2% | +$321K |
|
|
GBT
68
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $18.2M | 0.5% | 288,279 +8,279 | +3% | +$523K |
|
69
Theravance Biopharma
TBPH
$699M
| $17.4M | 0.48% | 828,218 +78,218 | +10% | +$1.64M |
|
|
ALLK
70
DELISTED
Allakos
ALLK
| $17.2M | 0.47% | 239,032 +4,032 | +2% | +$290K |
|
71
Compugen
CGEN
$132M
| $17M | 0.47% | 1,130,375 +30,375 | +3% | +$456K |
|
|
MYOK
72
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $16.7M | 0.46% | 172,716 +7,716 | +5% | +$746K |
|
|
FUSN
73
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $16.4M | 0.45% | +937,041 | New | +$16.4M |
|
74
Arvinas
ARVN
$568M
| $16.1M | 0.44% | 481,468 +196,468 | +69% | +$6.59M |
|
75
West Pharmaceutical
WST
$17.8B
| $16.1M | 0.44% | 71,000 | – | – |
|